BTIG Reiterates Buy on Organogenesis Holdings, Maintains $9 Price Target

Benzinga · 1d ago
BTIG analyst Ryan Zimmerman reiterates Organogenesis Holdings (NASDAQ:ORGO) with a Buy and maintains $9 price target.